Allogene Therapeutics (ALLO) EBT Margin (2021 - 2026)
Allogene Therapeutics (ALLO) recorded EBT Margin of -918.45% in Q2 2026.
Powered by 
Analysis
Allogene Therapeutics (ALLO) EBT Margin (2021 - 2026) Analysis & Trends
On a TTM basis, Allogene Therapeutics' EBT Margin came in at -3573.51% as of Jun 30, 2026; for FY2024, it came in at -1168850.00%, down 824360.53 percentage points from FY2023.
- Annual EBT Margin has declined for three straight years, with a three-year change of -1168624.73 percentage points (FY2021 to FY2024).
- Across earlier years, EBT Margin came in at -344489.47% in FY2023 (-132329.22 pp), -212160.26% in FY2022 (-211934.99 pp) and -225.27% in FY2021.
- The Q2 2026 figure is the highest quarterly EBT Margin since Q4 2021.
- Peak year-over-year performance for EBT Margin in the last five years was a gain of 43744.28 percentage points in Q3 2023, against a drop of 360148.66 percentage points in Q4 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 26.66% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -4.34% |
| 10 | Allogene Therapeutics | 435.17 Mn | -666.72 Mn | - | -918.45% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -918.45% |
| Mar 31, 2024 | -291,231.82% |
| Dec 31, 2023 | -375,447.62% |
| Sep 30, 2023 | -258,140.91% |
| Jun 30, 2023 | -348,918.18% |
| Mar 31, 2023 | -323,443.33% |
| Dec 31, 2022 | -360,146.15% |
| Sep 30, 2022 | -301,885.19% |
| Jun 30, 2022 | -119,220.31% |
| Mar 31, 2022 | -203,902.56% |
| Dec 31, 2021 | 2.50% |
| Sep 30, 2021 | -157,708.16% |
| Jun 30, 2021 | -160,011.36% |
| Mar 31, 2021 | -86.58% |
API Access
Allogene Therapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=ALLO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "ALLO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=ALLO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();